Author
Listed:
- Armin Rehm
(Oncology and Tumorimmunology, Max-Delbrück-Center for Molecular Medicine, MDC
Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum)
- Marcel Gätjen
(Oncology and Tumorimmunology, Max-Delbrück-Center for Molecular Medicine, MDC)
- Kerstin Gerlach
(Oncology and Tumorimmunology, Max-Delbrück-Center for Molecular Medicine, MDC)
- Florian Scholz
(Max-Delbrück-Center for Molecular Medicine, MDC)
- Angela Mensen
(Oncology and Tumorimmunology, Max-Delbrück-Center for Molecular Medicine, MDC
Present address: Charité-Universitätsmedizin Berlin, Institute for Medical Immunology, 13353 Berlin, Germany)
- Marleen Gloger
(Oncology and Tumorimmunology, Max-Delbrück-Center for Molecular Medicine, MDC)
- Kristina Heinig
(Max-Delbrück-Center for Molecular Medicine, MDC)
- Björn Lamprecht
(Oncology and Tumorimmunology, Max-Delbrück-Center for Molecular Medicine, MDC)
- Stephan Mathas
(Oncology and Tumorimmunology, Max-Delbrück-Center for Molecular Medicine, MDC
Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum)
- Valérie Bégay
(Max-Delbrück-Center for Molecular Medicine, MDC)
- Achim Leutz
(Max-Delbrück-Center for Molecular Medicine, MDC)
- Martin Lipp
(Max-Delbrück-Center for Molecular Medicine, MDC)
- Bernd Dörken
(Oncology and Tumorimmunology, Max-Delbrück-Center for Molecular Medicine, MDC
Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum)
- Uta E. Höpken
(Max-Delbrück-Center for Molecular Medicine, MDC)
Abstract
The capacity of dendritic cells (DCs) to regulate tumour-specific adaptive immune responses depends on their proper differentiation and homing status. Whereas DC-associated tumour-promoting functions are linked to T-cell tolerance and formation of an inflammatory milieu, DC-mediated direct effects on tumour growth have remained unexplored. Here we show that deletion of DCs substantially delays progression of Myc-driven lymphomas. Lymphoma-exposed DCs upregulate immunomodulatory cytokines, growth factors and the CCAAT/enhancer-binding protein β (C/EBPβ). Moreover, Eμ-Myc lymphomas induce the preferential translation of the LAP/LAP* isoforms of C/EBPβ. C/EBPβ−/− DCs are unresponsive to lymphoma-associated cytokine changes and in contrast to wild-type DCs, they are unable to mediate enhanced Eμ-Myc lymphoma cell survival. Antigen-specific T-cell proliferation in lymphoma-bearing mice is impaired; however, this immune suppression is reverted by the DC-restricted deletion of C/EBPβ. Thus, we show that C/EBPβ-controlled DC functions are critical steps for the creation of a lymphoma growth-promoting and -immunosuppressive niche.
Suggested Citation
Armin Rehm & Marcel Gätjen & Kerstin Gerlach & Florian Scholz & Angela Mensen & Marleen Gloger & Kristina Heinig & Björn Lamprecht & Stephan Mathas & Valérie Bégay & Achim Leutz & Martin Lipp & Bernd , 2014.
"Dendritic cell-mediated survival signals in Eμ-Myc B-cell lymphoma depend on the transcription factor C/EBPβ,"
Nature Communications, Nature, vol. 5(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6057
DOI: 10.1038/ncomms6057
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6057. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.